Ren-Sheng Wang (Rensheng Wang)
Publication Activity (10 Years)
Years Active: 2019-2022
Publications (10 Years): 12
Publications (10 Years): 12
Publications
- Jia-Ying Wen, Ye-Ying Fang, Gang Chen, Rong-Quan He, He-Qing Huang, Ren-Sheng Wang, Da-Tong Zeng, Wei-Jian Huang, Xin-Gan Qin
- Jing-Lin Mi, Meng Xu, Chang Liu, Ren-Sheng Wang
- Jia-Ying Wen, Gang Chen, Jian-Di Li, Jia-Yuan Luo, Juan He, Ren-Sheng Wang, Li-Ting Qin
- Jia-Ying Wen, Li-Ting Qin, Gang Chen, He-Qing Huang, Ming-Jun Shen, Jin-Shu Pang, Yu-Xing Tang, Wei Lu, Ren-Sheng Wang, Jia-Yuan Luo
- Yong Zhang, Xiaobi Tang, Shanshan Ma, Meizhu Shen, Li Jiang, Wenchao Yuan, Ren-Sheng Wang, Fang Wu
- Chang Liu, Wenling Wu, Meng Xu, Jinglin Mi, Longjiang Xu, Ren-Sheng Wang
- Leifeng Liang, Zhibing Liu, Haisheng Zhu, Hongqian Wang, Yan Wei, Xuejian Ning, Zhiling Shi, Liujun Jiang, Zhan Lin, Haolin Yan, Ren-Sheng Wang, Kai Hu
- Shaodong Hong, Ya-Xiong Zhang, Gengsheng Yu, Peijian Peng, Jiewen Peng, Jun Jia, Xuan Wu, Yan Huang, Yunpeng Yang, Qing Lin, Xuping Xi, Mingjun Xu, Dongping Chen, Xiaojun Lu, Ren-Sheng Wang, Xiaolong Cao, Xiaozhong Chen, Zhixiong Lin, Jianping Xiong, Qin Lin, Conghua Xie, Zhihua Li, Jianji Pan, Jingao Li, Shixiu Wu, Yingni Lian, Quanlie Yang, Chong Zhao, Wenfeng Fang, Li ZhangGemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (29) (2021)
- Jing-Lin Mi, Meng Xu, Chang Liu, Ren-Sheng Wang
- Zhen Meng, Feifei Gao, Chang Liu, Shengcai Huang, Kai Hu, Ren-Sheng Wang
- Kang Liu, Min Kang, Xiwen Liao, Ren-Sheng Wang